vaccine candidates, the Financial Times reported, citing people involved in the project. So-called "challenge trials" are expected to begin in January at a quarantine facility in London, the report said, adding that about 2,000 participants had signed up through a US-based advocacy group, 1Day Sooner.Britain said it was working with partners on the potential for human challenge trials without commenting on a specific plan."We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies," a government spokeswoman said."These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic.